The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II trial of concurrent chemoradiation with consolidation pembrolizumab in patients with unresectable stage III non-small cell lung cancer: Hoosier Cancer Research Network LUN 14-179.
 
Greg Andrew Durm
Research Funding - Bristol-Myers Squibb (Inst); Merck (Inst)
 
Sandra K. Althouse
No Relationships to Disclose
 
Ahad Ali Sadiq
No Relationships to Disclose
 
Shadia Ibrahim Jalal
Research Funding - AstraZeneca/MedImmune
 
Salma Jabbour
Research Funding - Merck Sharp & Dohme; Nestle health science (Inst)
 
Robin Zon
Consulting or Advisory Role - MedPro Specialty Advisory Board
Research Funding - Agendia (Inst)
Other Relationship - MedPro Specialty Advisory Board
 
Goetz H. Kloecker
Honoraria - AstraZeneca; Bristol-Myers Squibb; Genentech/Roche; Merck; Novartis; Sanofi
Consulting or Advisory Role - Lilly; Novartis
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Genentech/Roche; Lilly; Merck
Research Funding - Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Genentech/Roche; Lilly; Merck; Novartis
 
William B. Fisher
No Relationships to Disclose
 
Karen L. Reckamp
Consulting or Advisory Role - Amgen; ARIAD; Astellas Pharma; Boehringer Ingelheim; Euclises; Takeda; Tesaro
Research Funding - Abbvie; Adaptimmune (Inst); ARIAD (Inst); Boehringer Ingelheim; Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Novartis (Inst); Pfizer (Inst); Pfizer (Inst); Xcovery (Inst)
 
Ebenezer A. Kio
Stock and Other Ownership Interests - Eisai; GlaxoSmithKline; Lilly
Consulting or Advisory Role - Celgene; Lilly
Research Funding - Abbvie (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Lilly; Pharmacyclics
 
Robert M. Langdon
No Relationships to Disclose
 
Bamidele Adesunloye
No Relationships to Disclose
 
Ryan D. Gentzler
Honoraria - Merck
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Takeda
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst); Merck (Inst)
 
Nasser H. Hanna
Research Funding - Bristol-Myers Squibb (Inst); Merck KGaA (Inst)